Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) announced several board changes today, including the appointment of Richard Hathaway as a non-executive director with effect from 1 February.
The cannabinoid pharmaceutical development company says Hathaway was nominated following an agreement between Oxford Cannabinoid and Imperial Brands Ventures Limited, a 10.87% shareholder, as its representative after the resignation of Bishrut Mukherjee in September 2021.
Hathaway is corporate development director at Imperial Brands, where he is responsible for leading mergers and acquisitions as well as other strategic initiatives.
He previously held a partner position at KPMG, where he was experienced in auditing and advising companies across a wide range of sectors.
"We are delighted to welcome Richard Hathaway to the board as our new non-executive director, where his own extensive financial and corporate experience will be of great benefit to the company,” said chief executive John Lucas.
The company also confirmed that Julie Pomeroy, currently an independent non-executive director, will step up to the role of non-executive chair with effect from 11 February.
Executive chairman Neil Mahapatra will step down from his current role but remain on the board as a non-executive director, as flagged in November.